Bissen-Miyajima Hiroko, Ota Yuka, Yaguchi Saori, Nakamura Kunihiko, Sasaki Noriyuki
Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.
Alcon Japan Ltd, Tokyo, Japan.
Clin Ophthalmol. 2024 Mar 8;18:755-763. doi: 10.2147/OPTH.S448427. eCollection 2024.
To evaluate the effectiveness and safety of the AcrySof IQ PanOptix toric intraocular lens (IOL) with cylinder power of 1.0 D (TFNT20) in a Japanese population with low corneal astigmatism and compare with historical control data for nontoric IOLs.
Tokyo Dental College Suidobashi Hospital, Tokyo, Japan.
Prospective, single-center study.
Patients ≥20 years old received TFNT20 IOL in at least 1 eye based on Alcon Toric calculator (Holladay Total surgically induced astigmatism). Effectiveness endpoints included the percentage of eyes with refractive cylinder ≤0.25 D at 30-60 days after surgery, which was compared with a historical control threshold rate of 29.2% for nontoric IOLs and refractive cylinder ≤0.50 D. Monocular uncorrected distance visual acuity (UDVA; 5 m), uncorrected intermediate visual acuity (UIVA; 60 cm), uncorrected near visual acuity (UNVA; 40 cm), and adverse events were evaluated.
Of 41 eyes implanted with TFNT20 IOLs, 37 eyes (90%) achieved refractive cylinder ≤0.25 D at 30-60 days after surgery, demonstrating the superiority of TFNT20 compared with historical data (<0.0001). Refractive cylinder of ≤0.50 D was achieved by 41 eyes (100%). At 30-60 days, mean ± SD monocular CDVA was -0.15 ± 0.07 logMAR, UDVA was -0.09 ± 0.09 logMAR, UIVA was -0.00 ± 0.07 logMAR, and UNVA was 0.03 ± 0.07 logMAR. Six eyes (15%) had elevated postoperative intraocular pressure, which returned to normal and was not device-related.
TFNT20 IOLs successfully reduced postoperative refractive cylinder and provided good distance, intermediate, and near uncorrected VAs in Japanese patients with low corneal astigmatism.
评估柱镜度数为1.0 D的AcrySof IQ PanOptix散光型人工晶状体(IOL)(TFNT20)在日本低角膜散光人群中的有效性和安全性,并与非散光型IOL的历史对照数据进行比较。
日本东京齿科大学水道桥医院。
前瞻性单中心研究。
年龄≥20岁的患者至少一只眼植入基于爱尔康散光计算器(霍拉迪全手术诱导散光)的TFNT20 IOL。有效性终点包括术后30 - 60天屈光性柱镜度数≤0.25 D的眼的百分比,并与非散光型IOL的历史对照阈值率29.2%以及屈光性柱镜度数≤0.50 D进行比较。评估单眼未矫正远视力(UDVA;5米)、未矫正中视力(UIVA;60厘米)、未矫正近视力(UNVA;40厘米)和不良事件。
41只眼植入TFNT20 IOL,其中37只眼(90%)在术后30 - 60天达到屈光性柱镜度数≤0.25 D,表明TFNT20与历史数据相比具有优越性(<0.0001)。41只眼(100%)达到屈光性柱镜度数≤0.50 D。在术后30 - 60天,平均±标准差单眼矫正视力(CDVA)为-0.15±0.07 logMAR,UDVA为-0.09±0.09 logMAR,UIVA为-0.00±0.07 logMAR,UNVA为0.03±0.07 logMAR。6只眼(15%)术后眼压升高,但恢复正常且与器械无关。
TFNT20 IOL成功降低了术后屈光性柱镜度数,并为日本低角膜散光患者提供了良好的远、中、近未矫正视力。